Toll Free: 1-888-928-9744

Kinex Pharmaceuticals, LLC - Product Pipeline Review - 2014

Published: Sep, 2014 | Pages: 35 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Kinex Pharmaceuticals, LLC - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Kinex Pharmaceuticals, LLC - Product Pipeline Review - 2014', provides an overview of the Kinex Pharmaceuticals, LLC's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Kinex Pharmaceuticals, LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Kinex Pharmaceuticals, LLC including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Kinex Pharmaceuticals, LLC's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Kinex Pharmaceuticals, LLC's pipeline products

Reasons to buy

- Evaluate Kinex Pharmaceuticals, LLC's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Kinex Pharmaceuticals, LLC in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Kinex Pharmaceuticals, LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Kinex Pharmaceuticals, LLC and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Kinex Pharmaceuticals, LLC
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Kinex Pharmaceuticals, LLC and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Kinex Pharmaceuticals, LLC Snapshot 5
Kinex Pharmaceuticals, LLC Overview 5
Key Information 5
Key Facts 5
Kinex Pharmaceuticals, LLC - Research and Development Overview 6
Key Therapeutic Areas 6
Kinex Pharmaceuticals, LLC - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Pipeline Products - Combination Treatment Modalities 11
Pipeline Products - Partnered Products 12
Partnered Products/Combination Treatment Modalities 13
Kinex Pharmaceuticals, LLC - Pipeline Products Glance 14
Kinex Pharmaceuticals, LLC - Clinical Stage Pipeline Products 14
Phase II Products/Combination Treatment Modalities 14
Phase I Products/Combination Treatment Modalities 15
Kinex Pharmaceuticals, LLC - Early Stage Pipeline Products 16
IND/CTA Filed Products/Combination Treatment Modalities 16
Preclinical Products/Combination Treatment Modalities 17
Kinex Pharmaceuticals, LLC - Drug Profiles 18
(paclitaxel + HM30181A) 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
KX-01 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
(irinotecan hydrochloride + HM30181A) 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
KX-02 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Small Molecule for Immunology 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Kinex Pharmaceuticals, LLC - Pipeline Analysis 24
Kinex Pharmaceuticals, LLC - Pipeline Products by Target 24
Kinex Pharmaceuticals, LLC - Pipeline Products by Route of Administration 25
Kinex Pharmaceuticals, LLC - Pipeline Products by Molecule Type 26
Kinex Pharmaceuticals, LLC - Pipeline Products by Mechanism of Action 27
Kinex Pharmaceuticals, LLC - Recent Pipeline Updates 28
Kinex Pharmaceuticals, LLC - Dormant Projects 32
Kinex Pharmaceuticals, LLC - Locations And Subsidiaries 33
Head Office 33
Appendix 34
Methodology 34
Coverage 34
Secondary Research 34
Primary Research 34
Expert Panel Validation 34
Contact Us 35
Disclaimer 35
List of Tables
Kinex Pharmaceuticals, LLC, Key Information 5
Kinex Pharmaceuticals, LLC, Key Facts 5
Kinex Pharmaceuticals, LLC - Pipeline by Indication, 2014 8
Kinex Pharmaceuticals, LLC - Pipeline by Stage of Development, 2014 9
Kinex Pharmaceuticals, LLC - Monotherapy Products in Pipeline, 2014 10
Kinex Pharmaceuticals, LLC - Combination Treatment Modalities in Pipeline, 2014 11
Kinex Pharmaceuticals, LLC - Partnered Products in Pipeline, 2014 12
Kinex Pharmaceuticals, LLC - Partnered Products/ Combination Treatment Modalities, 2014 13
Kinex Pharmaceuticals, LLC - Phase II, 2014 14
Kinex Pharmaceuticals, LLC - Phase I, 2014 15
Kinex Pharmaceuticals, LLC - IND/CTA Filed, 2014 16
Kinex Pharmaceuticals, LLC - Preclinical, 2014 17
Kinex Pharmaceuticals, LLC - Pipeline by Target, 2014 24
Kinex Pharmaceuticals, LLC - Pipeline by Route of Administration, 2014 25
Kinex Pharmaceuticals, LLC - Pipeline by Molecule Type, 2014 26
Kinex Pharmaceuticals, LLC - Pipeline Products by Mechanism of Action, 2014 27
Kinex Pharmaceuticals, LLC - Recent Pipeline Updates, 2014 28
Kinex Pharmaceuticals, LLC - Dormant Developmental Projects,2014 32 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify